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TO THE EDITOR
Generalized pustular psoriasis (GPP;
OMIM 614204) is a severe type of
psoriasis characterized by widespread
erythematous skin and sterile pustules
that affects up to 1.3% of psoriasis
patients (Takahashi et al., 2011). The
acute onset of GPP is typically associ-
ated with high-grade fever, rigor, and
toxicity. Acitretin is considered to be ﬁrst-
line therapy for GPP, and it appears to
provide better efﬁcacy as a single agent
in the treatment of pustular psoriasis
compared with psoriasis vulgaris (PV;
OMIM 177900) as a single agent treat-
ment (Sbidian et al., 2011). Using homo-
zygosity mapping and direct sequencing
in consanguineous Tunisian multiplex
families with autosomal recessive GPP,
Marrakchi et al. (2011) ﬁrst reported the
association between IL36RN and GPP.
A variety of missense and nonsense
changes in IL36RN have since been des-
cribed in European and Asian patients.
Individuals with an IL36RN mutation
show upregulated IL1 expression, which
likely accounts for the occurrence of
systemic inﬂammation and peripheral
neutrophilia, two cardinal features of
GPP (Onoufriadis et al., 2011). How-
ever, the percentages of IL36RN-nega-
tive patients have been reported to
range from 51% (Li et al., 2013) to 84%
(Setta-Kaffetzi et al., 2013), implying t
hat additional risk loci, genetic interac-
tions, and other factors account for the
remaining GPP occurrence. Recently,
Jordan et al. (2012) identiﬁed the
mutation c.413A4C (p.Glu138Ala) in
CARD14 in a child with sporadic, early-
onset GPP, which indicates that
CARD14 is another candidate gene
responsible for GPP.
Compared with GPP, PV has been
intensively studied, and numerous risk-
associated variants within 44 suscept-
ibility loci have been discovered (Tang
et al., 2014). Among these susceptibility
loci, IL36RN was not reported to be
associated with PV. Furthermore, HLA-
Cw6, the major susceptibility deter-
minant for PV, is not associated with
GPP (Grifﬁths and Barker, 2010).
To identify the relationship between
GPP and PV, further our understanding
of GPP, and detect other susceptibility
genes/loci, we performed a candidate
loci study in GPP patients. GPP cases
and healthy controls were recruited
from multiple hospitals in the central
areas of China (Shanghai and Shandong
provinces). The patients were isolated
individuals of Chinese origin with typi-
cal clinical presentations or pathologic
features. A total of 238 patients and 421
controls were included in the analysis.
The clinical characteristics of the cases
and controls are indicated in
Supplementary Table S1 online. The
study was approved by the Ethics
Committee of Fudan University Hua-
shan Hospital and was conducted
according to the principles of the
Declaration of Helsinki. All the partici-
pants signed informed consent about
this experiment. For the selection of the
single-nucleotide polymorphisms (SNPs),
we searched published genome-wide
association study (GWAS) on PV from
the GWAS catalog and summarized the
reported susceptibility loci. Using Hap-
Map data (Han Chinese in Beijing,
China), we identiﬁed the most signiﬁ-
cant SNPs of the linkage disequilibrium
(LD) region and excluded redundant and
monomorphic SNPs in Chinese popula-
tion; in total, 50 SNPs were ultimately
selected (Supplementary Table S2 online).
Allele detection was performed using
matrix-assisted laser desorption/ionization
time of ﬂight mass spectroscopy. The
mass spectrograms were analyzed with
MassARRAY TYPER software (Sequenom,
San Diego, CA). Minor allele frequency
was 41% with P40.01 for Hardy–
Weinberg equilibrium in the controls,
and SNPs with call rates higher than
95% in the cases or controls were used in
accordance with the SNP quality criteria.
For the association testing, the Armitage
trend test was employed to detect allelicAccepted article preview online 24 March 2015; published online 9 April 2015
Abbreviations: GPP, generalized pustular psoriasis; GWAS, genome-wide association study; IPA,
ingenuity pathway analysis; LD, linkage disequilibrium; OR, odds ratio; PV, psoriasis vulgaris; RAR,
retinoic acid receptor; SNP, single-nucleotide polymorphism
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and genotypic effects using Plink 1.07
software (Harvard, Boston, MA). Conser-
vatively, accounting for multiple testing
with the Bonferroni correction, the thresh-
old for statistical signiﬁcance, was
Po2.00×10−4. QIAGEN’s Ingenuity
Pathway analysis (IPA; QIAGEN Red-
wood City, www.qiagen.com/ingenuity)
was used for canonical pathway enrich-
ment analysis and derivation of the
mechanistic networks.
After Bonferroni correction, we iden-
tiﬁed two susceptibility loci at 5q33.1
and 17q25.3 and one potential suscept-
ibility locus at 8p23.2 (Table 1 and
Supplementary Table S3 online). The
most signiﬁcant SNPs were located at
5q33.1 (rs3762999, P= 2.15×10− 10,
odds ratio (OR)= 2.23; rs999556,
P=1.09×10−9, OR= 2.15), and these
two SNPs were in strong LD with each
other (D′=1, r2= 0.97). There were two
genes in this region––TNIP1 and ANXA6
(Sun et al., 2010). No functional analysis
within this region has been previously
performed, and the actual contribution
to disease risk remains unknown.
To better characterize this region, we
performed pathway analysis using the
IPA tool (Supplementary Table S4 online
and Supplementary Figure S1 online).
Three cytokine signaling pathways
were signiﬁcantly associated with TNIP1
Table 1. Association evidence for four SNPs at three loci
SNP Chr Gene Allele1
MAF
P2 OR PHWE
3
Cases Controls
rs3762999 5q33.1 TNIP1,ANAA6 G 0.42 0.24 2.15E-10 2.23 1.00
rs999556 A 0.41 0.25 1.09E-09 2.15 0.80
rs3813063 17q25.3 CARD14 T 0.39 0.53 1.54E-06 0.57 0.92
rs10088247 8p23.2 CSMD1 C 0.30 0.22 3.87E-04 1.53 0.03
Abbreviations: Chr, chromosome; MAF, minor allele frequency; OR, odds ratio; SNP, single-nucleotide polymorphism.
1Minor allele.
2P-values from the trend test.
3PHWE from Hardy–Weinberg equilibrium test in controls.
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Figure 1. The most signiﬁcant network determined in ingenuity pathway analysis. Functional annotation networks show documented gene relationships among
the reported GPP-associated genes. Genes/proteins are illustrated as nodes and molecular relationships as connecting lines between two nodes (direct
relationships as normal lines; indirect relationships as dashed lines). GPP, generalized pustular psoriasis; TNF, tumor necrosis factor.
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(including angiopoietin signaling, NF-κB
signaling, and retinoic acid receptor
(RAR) activation), which led to the desi-
gnation of TNIP1 as a candidate gene in
this region. The RAR activation pathway
is responsive to vitamin A and its active
retinoid derivatives. There are three
different RAR isotypes (α, β, and γ).
TNIP1 colocalizes with RAR-α in human
epidermal keratinocytes, a known
retinoid-sensitive cell type. RARs can
antagonize transcriptional activation via
NF-κB activation and subsequent inﬂam-
matory or hyperproliferative responses
(Supplementary Figure S1 online). More-
over, TNIP1 encoded protein binds
to the product of another psoriasis-
associated gene (TNFAIP3). Together
these observations may explain why
acitretin represents one of the best
choices for GPP.
The other susceptibility locus 17q25.3
was also associated with GPP (rs3813063,
P=1.54× 10−6, OR=0.57). SNP
rs11652075, which is found in
the 17q25.3 locus, is a missense muta-
tion in the gene CARD14 (c.2458C4T
(p.Arg820Trp)) and is associated with
PV in both Chinese and Caucasian
populations (Jordan et al., 2012; Tsoi
et al., 2012; Cheng et al., 2014).
Although our experiment failed to geno-
type SNP rs11652075 with the Seque-
nom platform, the SNP we found has
high correlation with the missense
mutation c.2458C4T (D′=1, r2=0.95).
Recently, several rare variants in
CARD14 have been proven to be
associated with GPP (Jordan et al.,
2012; Qin et al., 2014; Sugiura et al.,
2014); our study ﬁrst proved that the
common SNP rs3813063 in this gene
was also associated with GPP, and the
result further strengthens the association
between CARD14 and GPP. CARD14
encodes caspase recruitment domain
family member 14, an activator of NF-
κB chain in B cells (Bertin et al., 2001).
Jordan et al. (2012) shown that NF-κB
pathway alterations can occur at the
level of keratinocyte.
The potential susceptibility locus
8p23.2 (rs10088247, P=3.87× 10−4,
OR=1.53) contains only one gene
CSMD1, which is a tumor suppressor
gene expressed in areas of regenerative
growth, such as the skin and epithelial
cells. The P-value of this association is
not very signiﬁcant. Therefore, CSMD1
is only a potential candidate gene
for GPP.
To further explore the associated and
potentially associated genes (IL36RN,
IL1/IL6/TNF, TNIP1, ANXA6, CARD14,
and CSMD1), we used the IPA program
to identify the most signiﬁcant networks
and canonical pathways based on a
calculated probability score. The NF-κB
signaling pathway (P=2.57×10−5,
OR=0.014) was the most commonly
identiﬁed pathway. This result further
strengthened our above hypothesis
regarding GPP. The most signiﬁcant net-
work generated by IPA from the asso-
ciated genes is displayed in Figure 1, and
the functions of this pathway included
tissue morphology, dermatological con-
ditions, and molecular transplant.
In conclusion, this study has per-
formed an association analysis using a
large sample of GPP patients. Two PV
susceptibility loci have been proved to
be associated with GPP. As one subtype
of psoriasis, GPP displays unique patho-
genic feature but partly shares genetic
bases with PV. On the basis of our
research, GPP-associated genes
detected by linkage and association
studies can be plausibly involved in
one biological pathway. These results
may provide clues to the genetics
of GPP.
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